Trial Profile
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ulobetasol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Pharmacokinetics
- 13 Jan 2012 Actual number of patients 43 added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2011 Planned end date changed from Dec 2010 to Jul 2011 as reported by ClinicalTrials.gov.